Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of RTS,S/AS02D Malaria Vaccine Schedules in Ghanaian Children
NCT00360230Phase 2Completed
- Sponsor
- GSK
- Start
- Aug 2006
- Primary completion
- Aug 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of RTS,S in malaria, sponsored by GSK. Started Aug 2006; status: completed.
02
Drugs
RTS,S
03
Conditions
malaria
Beyond the preview
Go deeper on NCT00360230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00360230.